TOP2A and vibrio infectious disease: Owing to cross resistance with nalidixic acid (secondary to a single mutation in the gyrA gene coding the DNA gyrase) and the high worldwide resistance patterns to nalidixic acid [30], ciprofloxacin is not recommended for use in cholera.